by Jennifer P | Mar 29, 2021 | OTC Drugs, U.S. Regulatory
In March 2020, provisions were added to the Federal Food, Drug, and Cosmetic Act by the Coronavirus Aid, Relief, and Economic Security (CARES) Act, which authorize FDA to assess and collect user fees from qualifying manufacturers of OTC monograph drugs and submitters...
by Jennifer P | Mar 12, 2021 | Canadian Regulatory, Cosmetics, Natural Health Products, OTC Drugs
Health Canada has announced that there will be updates to the approach to regulating self-care products as part of their 2020-2022 Forward Regulatory Plan. The self-care framework will roll out in phases over the coming years: Phase I – Target Spring 2021 will include...
by Jennifer P | Mar 7, 2021 | Canadian Regulatory, OTC Drugs
The deadline for the first step of Health Canada’s new risk evaluation for the presence of N-nitrosamine impurities in Canadian human pharmaceutical, biological and radiopharmaceutical products is fast approaching. This new Health Canada requirement for all Market...
by Emily C | May 20, 2020 | Canadian Regulatory, Medical Devices
In March, Health Canada put in place an interim policy for their regulations for hand sanitizers and disinfectant products. This was in response to the high supply and demand for these types of products due to the COVID-19 pandemic, which caused a 735% increase in...
by Jennifer P | Mar 21, 2019 | Canadian Regulatory, Natural Health Products, Research/Science/Technology, U.S. Regulatory
The increasingly popular use of CBD in prepared food and drink in New York City is beginning to gain attention for its questionable legality. The New York City Department of Health confirmed that it is starting to place focus on restaurants that use cannabidiol (CBD)...
Recent Comments